This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Aug 1;4(8):1134-1135.

doi: 10.1001/jamaoncol.2018.0895.

Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas-Reply

Antoine Italiano^{1

2

3}

Affiliations

Affiliations

¹ Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
² University of Bordeaux, Bordeaux, France.
³ Department of Surgery, Institut Bergonié, Bordeaux, France.

PMID: 29902304
DOI: 10.1001/jamaoncol.2018.0895

Comment

Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas-Reply

Antoine Italiano. JAMA Oncol. 2018.

. 2018 Aug 1;4(8):1134-1135.

doi: 10.1001/jamaoncol.2018.0895.

Author

Antoine Italiano^{1

2

3}

Affiliations

¹ Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
² University of Bordeaux, Bordeaux, France.
³ Department of Surgery, Institut Bergonié, Bordeaux, France.

PMID: 29902304
DOI: 10.1001/jamaoncol.2018.0895

No abstract available

PubMed Disclaimer

Comment on

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.
Toulmonde M, Penel N, Adam J, Chevreau C, Blay JY, Le Cesne A, Bompas E, Piperno-Neumann S, Cousin S, Grellety T, Ryckewaert T, Bessede A, Ghiringhelli F, Pulido M, Italiano A. Toulmonde M, et al. JAMA Oncol. 2018 Jan 1;4(1):93-97. doi: 10.1001/jamaoncol.2017.1617. JAMA Oncol. 2018. PMID: 28662235 Free PMC article. Clinical Trial.
Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas.
Macciò A, Madeddu C. Macciò A, et al. JAMA Oncol. 2018 Aug 1;4(8):1134. doi: 10.1001/jamaoncol.2018.0875. JAMA Oncol. 2018. PMID: 29902292 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program